New England Capital Financial Advisors’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
Other funds holding MDT
New England Capital Financial Advisors's MDT Position: Q2 2026 in Review
New England Capital Financial Advisors reduced its Medtronic (MDT) stake by 13% in Q2 2026, selling an estimated $14.5K and leaving 1,225 shares worth $95.8K. The position accounts for 0.02% of the portfolio, ranked #92.
New England Capital Financial Advisors first reported a position in MDT in Q4 2022 and has held it in 15 quarters since. The position peaked at $135K in Q4 2025. 1,560 funds tracked by Wall St. Rank hold MDT as of Q2 2026.
- New England Capital Financial Advisors held 1,225 shares of Medtronic worth $95.8K as of Q2 2026.
- New England Capital Financial Advisors sold 180 Medtronic shares in Q2 2026, an estimated $14.5K.
- Medtronic made up 0.02% of New England Capital Financial Advisors's portfolio in Q2 2026, its #92 holding.
- New England Capital Financial Advisors first reported a position in Medtronic in Q4 2022 and has held it in 15 quarters since.
- New England Capital Financial Advisors's Medtronic position peaked at $135K in Q4 2025.
- 1,560 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.
Based on New England Capital Financial Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.